Skip to main content

Advertisement

SpringerLink
Log in

Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy

  • Research Article
  • Published:
Tumor Biology

Abstract

Genetic polymorphisms in drug metabolism and transport genes can influence the pharmacokinetics and pharmacodynamics of chemotherapy drugs. We investigated the role of genes involved in metabolic and transport pathways in response to chemotherapy and clinical outcome of osteosarcoma patients. The association between the eight polymorphisms with response to chemotherapy and clinical outcome of patients was carried out by unconditional logistic regression analysis and Cox proportional hazard models. Of 186 patients, 98 patients showed good response to chemotherapy, 64 died, and 97 showed progression at the end of the study. Patients carrying ABCB1 rs1128503 TT genotype and T allele were more likely to have a good response to chemotherapy. ABCC3 rs4148416 TT genotype and T allele and GSTP1 rs1695 GG genotype and G allele were associated with poor response to chemotherapy. In the Cox proportional hazards model, after adjusting for potential confounding factors, patients carrying ABCB1 rs1128503 TT genotype and T allele were associated with lower risk of progression-free survival (PFS) and overall survival (OS). ABCC3 rs4148416 TT genotype and T allele and GSTP1 rs1695 GG genotype and G allele were correlated with high risk of PFS and OS. The ABCB1 TT and GSTP1 GG genotypes were significantly associated with a shorter OS. In conclusion, variants of ABCB1 rs128503, ABCC3 rs4148416, and GSTP1 rs1695 are associated with response to chemotherapy and PFS and OS of osteosarcoma patients; these gene polymorphisms could help in the design of individualized therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.

    Article  PubMed  Google Scholar 

  2. Meazza C, Luksch R, Daolio P, et al. Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents. Med Oncol. 2014;31(4):875.

    Article  PubMed  Google Scholar 

  3. Ando K, Heymann MF, Stresing V, Mori K, Rédini F, Heymann D. Current therapeutic strategies and novel approaches in osteosarcoma. Cancers (Basel). 2013;5(2):591–616.

    Article  CAS  Google Scholar 

  4. Wittig JC, Bickels J, Priebat D, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002;65(6):1123–32.

    PubMed  Google Scholar 

  5. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev. 2006;32(6):423–36.

    Article  PubMed  Google Scholar 

  6. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776–90.

    Article  PubMed  Google Scholar 

  7. Oeffinger KC, Mertens AC, Sklar CA, et al. Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.

    Article  CAS  PubMed  Google Scholar 

  8. Redlich G, Zanger UM, Riedmaier S, et al. Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry. J Proteome Res. 2008;7(11):4678–88.

    Article  CAS  PubMed  Google Scholar 

  9. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445–600.

    Article  CAS  PubMed  Google Scholar 

  10. Zhou SF, Di YM, Chan E, et al. Clinical pharmacogenetics and potential application in personalized medicine. Curr Drug Metab. 2008;9(8):738–84.

    Article  CAS  PubMed  Google Scholar 

  11. Yang J, Wang ZG, Cai HQ, Li YC, Xu YL. Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy. Asian Pac J Cancer Prev. 2013;14(8):4595–8.

    Article  PubMed  Google Scholar 

  12. Caronia D, Patiño-Garcia A, Peréz-Martínez A, et al. Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study. PLoS One. 2011;6(10):e26091.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Zhang SL, Mao NF, Sun JY, Shi ZC, Wang B, Sun YJ. Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy. Asian Pac J Cancer Prev. 2012;13(6):2705–9.

    Article  PubMed  Google Scholar 

  14. Pasello M, Manara MC, Michelacci F, et al. Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy. Anal Cell Pathol (Amst). 2011;34(3):131–45.

    Article  CAS  Google Scholar 

  15. Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer. 2003;97(12):3068–75.

    Article  CAS  PubMed  Google Scholar 

  16. Leschziner GD, Andrew T, Pirmohamed M, Johnson MR. ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. Pharmacogenomics J. 2007;7(3):154–79.

    Article  CAS  PubMed  Google Scholar 

  17. Samanian S, Mahjoubi F, Mahjoubi B, Mirzaee R, Azizi R. MDR1 gene polymorphisms: possible association with its expression and clinicopathology characteristics in colorectal cancer patients. Asian Pac J Cancer Prev. 2011;12(11):3141–5.

    PubMed  Google Scholar 

  18. Wei L, Song XR, Wang XW, Li M, Zuo WS. Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance. Zhonghua Zhong Liu Za Zhi. 2006;28(6):445–8.

    CAS  PubMed  Google Scholar 

  19. Windsor RE, Strauss SJ, Kallis C, Wood NE, Whelan JS. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. Cancer. 2012;118(7):1856–67.

    Article  CAS  PubMed  Google Scholar 

  20. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 2000;92(16):1295–302.

    Article  CAS  PubMed  Google Scholar 

  21. Rost D, König J, Weiss G, Klar E, Stremmel W, Keppler D. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology. 2001;121(5):1203–8.

    Article  CAS  PubMed  Google Scholar 

  22. Grant CE, Gao M, DeGorter MK, Cole SP, Deeley RG. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab Dispos. 2008;36(12):2571–81.

    Article  CAS  PubMed  Google Scholar 

  23. Ketterer B. Glutathione S-transferases and prevention of cellular free radical damage. Free Radic Res. 1998;28(6):647–58.

    Article  CAS  PubMed  Google Scholar 

  24. Hengstler JG, Kett A, Arand M, et al. Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Lett. 1998;130(1–2):43–8.

    Article  CAS  PubMed  Google Scholar 

  25. Sun N, Sun X, Chen B, et al. MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2010;65(3):437–46.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Goekkurt E, Hoehn S, Wolschke C, et al. Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)—novel predictors for response and survival in gastric cancer patients. Br J Cancer. 2006;94(2):281–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Yang LM, Li XH, Bao CF. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors. Asian Pac J Cancer Prev. 2012;13(11):5883–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, China

    Shizhang Liu, Zhi Yi, Ming Ling, Jiyuan Shi & Yusheng Qiu

  2. Department of Child and Maternal Health, West China School of Public Health, Sichuan University, Chengdu, 710061, China

    Shujuan Yang

Authors
  1. Shizhang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ming Ling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jiyuan Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yusheng Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shujuan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yusheng Qiu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, S., Yi, Z., Ling, M. et al. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy. Tumor Biol. 35, 9897–9904 (2014). https://doi.org/10.1007/s13277-014-1917-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1917-x

Keywords

Search

Navigation